Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -3.88 Million AUD | -23.57% |
| 2022 | -3.14 Million AUD | -27.16% |
| 2021 | -2.47 Million AUD | 6.93% |
| 2020 | -2.65 Million AUD | -42.89% |
| 2019 | -1.85 Million AUD | 40.14% |
| 2018 | -3.1 Million AUD | -15542.24% |
| 2017 | 20.1 Thousand AUD | 167416.67% |
| 2016 | 12.00 AUD | -99.78% |
| 2015 | 5492.60 AUD | -10.11% |
| 2014 | 6110.25 AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | -3.88 Million AUD | -23.57% |
| 2023 Q2 | -759.15 Thousand AUD | 0.0% |
| 2023 Q1 | -759.15 Thousand AUD | -258.03% |
| 2023 Q4 | 619.23 Thousand AUD | 0.0% |
| 2023 Q3 | 619.23 Thousand AUD | 181.57% |
| 2022 Q4 | 480.37 Thousand AUD | 0.0% |
| 2022 FY | -3.14 Million AUD | -27.16% |
| 2022 Q3 | 480.37 Thousand AUD | 163.81% |
| 2022 Q2 | -752.83 Thousand AUD | 0.0% |
| 2022 Q1 | -752.83 Thousand AUD | 2.34% |
| 2021 Q3 | -770.86 Thousand AUD | -191.05% |
| 2021 Q4 | -770.86 Thousand AUD | 0.0% |
| 2021 FY | -2.47 Million AUD | 6.93% |
| 2021 Q2 | 846.63 Thousand AUD | 0.0% |
| 2021 Q1 | 846.62 Thousand AUD | 304.54% |
| 2020 Q1 | 332.01 Thousand AUD | 189.64% |
| 2020 Q2 | 332.01 Thousand AUD | 0.0% |
| 2020 Q4 | -413.92 Thousand AUD | 0.0% |
| 2020 FY | -2.65 Million AUD | -42.89% |
| 2020 Q3 | -413.92 Thousand AUD | -224.67% |
| 2019 Q1 | 480.86 Thousand AUD | 153.62% |
| 2019 FY | -1.85 Million AUD | 40.14% |
| 2019 Q3 | -370.37 Thousand AUD | -177.02% |
| 2019 Q2 | 480.86 Thousand AUD | 0.0% |
| 2019 Q4 | -370.37 Thousand AUD | 0.0% |
| 2018 Q2 | -565.32 Thousand AUD | -0.0% |
| 2018 FY | -3.1 Million AUD | -15542.24% |
| 2018 Q3 | -896.77 Thousand AUD | -58.63% |
| 2018 Q1 | -565.32 Thousand AUD | -1252.7% |
| 2018 Q4 | -896.77 Thousand AUD | 0.0% |
| 2017 FY | 20.1 Thousand AUD | 167416.67% |
| 2017 Q3 | 49.04 Thousand AUD | -59.3% |
| 2017 Q4 | 49.04 Thousand AUD | 0.0% |
| 2017 Q2 | 120.48 Thousand AUD | 0.0% |
| 2017 Q1 | 120.48 Thousand AUD | 0.0% |
| 2016 FY | 12.00 AUD | -99.78% |
| 2015 FY | 5492.60 AUD | -10.11% |
| 2014 FY | 6110.25 AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | -1911.977% |
| Arrayit Corporation | 2.57 Million USD | 250.797% |
| Atlantic International Corp. | -154.23 Thousand USD | -2417.678% |
| Biocept, Inc. | -2.58 Million USD | -50.392% |
| Bioqual, Inc. | 7.42 Million USD | 152.269% |
| CardioGenics Holdings Inc | - USD | Infinity% |
| DermTech, Inc. | 276 Thousand USD | 1506.926% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.058% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 316.44% |
| iMD Companies, Inc. | -23.63 Thousand USD | -16328.121% |
| IDenta Corp. | 662.97 Thousand USD | 685.711% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 116.852% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | 5105.885% |
| InVitro International | 635.98 Thousand USD | 710.567% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 159.167% |
| Many Bright Ideas Technologies Inc. | - USD | Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | 455.374% |
| NovelStem International Corp. | 12 Thousand USD | 32459.292% |
| Optigenex Inc. | -102.96 Thousand USD | -3671.259% |
| PharmChem, Inc. | 3.9 Million USD | 199.455% |
| Proteome Sciences plc | 2.09 Million USD | 285.207% |
| Response Genetics, Inc | 3.94 Million USD | 198.506% |
| Rennova Health, Inc. | 6.26 Million USD | 161.949% |
| RushNet, Inc. | 1.1 Million USD | 451.536% |
| ScreenPro Security Inc. | 856.57 Thousand USD | 553.331% |
| Stella Diagnostics Inc. | - USD | Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | -861.769% |
| Todos Medical Ltd. | 4.31 Million USD | 190.095% |